succinylcholine has been researched along with Anti-MuSK Myasthenia Gravis in 33 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the effect of repeated suxamethonium doses during propofol-fentanyl-N2O/O2 anaesthesia in a 29-year-old woman with active myasthenia gravis receiving chronic pyridostigmine therapy." | 7.69 | Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis receiving long-term anticholinesterase therapy. ( Booij, LH; Robertson, EN; Vanlinthout, LE, 1994) |
| " Four of these patients developed prolonged postoperative apnea; the longest period of apnea was 6 hours." | 7.66 | Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis. ( Maharry, JM; Sack, RA, 1982) |
| "The neuromuscular block of myasthenia gravis has the characteristics of an antidepolarizing (competitive block), similar to that produced by d-tubocurarine in normal subjects: progressive decrease in muscle action potentials evoked by two or more nerve stimuli, posttetanic facilitation, posttetanic fatigue, inhibition of the depolarizing action of acetylcholine (ACh) or anticholinesterase compounds, and reversal of the block by ACh or anticholinesterase compounds." | 4.75 | Characteristics and mechanism of neuromuscular block in myasthenia gravis. ( Grob, D; Namba, T, 1976) |
| "We describe the effect of repeated suxamethonium doses during propofol-fentanyl-N2O/O2 anaesthesia in a 29-year-old woman with active myasthenia gravis receiving chronic pyridostigmine therapy." | 3.69 | Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis receiving long-term anticholinesterase therapy. ( Booij, LH; Robertson, EN; Vanlinthout, LE, 1994) |
| "Patients with myasthenia gravis (MG) have increased tolerance to the neuromuscular blocking properties of suxamethonium (SCh) and decamethonium (C10) and exhibit a reversal of the C10-induced block by neostigmine." | 3.66 | Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle. ( Johnson, BR; Kim, YI; Sanders, DB, 1983) |
| " Four of these patients developed prolonged postoperative apnea; the longest period of apnea was 6 hours." | 3.66 | Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis. ( Maharry, JM; Sack, RA, 1982) |
| "Our patient demonstrated two unusual features: (1) severe upper airway obstruction due to bilateral vocal cord paralysis at first manifestation of a myasthenic syndrome; and (2) precipitation of this syndrome following surgery and anesthesia with succinylcholine." | 3.66 | Vocal cord paralysis in myasthenia gravis following anesthesia. ( Colp, C; Kriplani, L; Nussbaum, M, 1980) |
| " These studies showed that preanesthetic neuromuscular monitoring can be used for precise NMBA dosing in myasthenia gravis patients." | 2.82 | Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review. ( Gubbels, M; Heytens, L; Jungbluth, H; Riazi, S; Snoeck, MMJ; van den Bersselaar, LR; Voermans, NC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (69.70) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 1 (3.03) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| van den Bersselaar, LR | 1 |
| Gubbels, M | 1 |
| Riazi, S | 1 |
| Heytens, L | 1 |
| Jungbluth, H | 1 |
| Voermans, NC | 1 |
| Snoeck, MMJ | 1 |
| Baraka, A | 6 |
| Brown, TC | 1 |
| GINSBERG, H | 1 |
| VAREJES, L | 1 |
| Levitan, R | 1 |
| Azar, I | 1 |
| Johnson, BR | 1 |
| Kim, YI | 1 |
| Sanders, DB | 1 |
| Maharry, JM | 1 |
| Sack, RA | 1 |
| Colp, C | 1 |
| Kriplani, L | 1 |
| Nussbaum, M | 1 |
| Vanlinthout, LE | 1 |
| Robertson, EN | 1 |
| Booij, LH | 1 |
| Baroody, M | 1 |
| Yazbeck, V | 1 |
| Grob, D | 1 |
| Namba, T | 1 |
| Stanski, DR | 1 |
| Lee, RG | 1 |
| MacCannell, KL | 1 |
| Karr, GW | 1 |
| Neigh, JL | 1 |
| Fassoulaki, A | 1 |
| Korényi-Both, A | 1 |
| Kelemen, G | 1 |
| Tabboush, Z | 1 |
| Abel, M | 1 |
| Eisenkraft, JB | 2 |
| Patel, N | 1 |
| Book, WJ | 1 |
| Mann, SM | 1 |
| Papatestas, AE | 1 |
| Hubbard, M | 1 |
| Richardson, J | 1 |
| Wainwright, AP | 1 |
| Brodrick, PM | 1 |
| Field, EJ | 1 |
| Caspary, EA | 1 |
| Carnegie, PR | 1 |
| Dolzhenko, AT | 1 |
| Roberts, DV | 1 |
| Wilson, A | 1 |
| Ellis, FR | 1 |
| Afifi, A | 1 |
| Muallem, M | 1 |
| Kachachi, T | 1 |
| Frayha, F | 1 |
| Chuliá Campos, V | 1 |
| Ortuño Borja, J | 1 |
| Seligra Ferrer, A | 1 |
| Cookson, JC | 1 |
| Paton, WD | 1 |
| Thomas, ET | 1 |
| Dobkin, AB | 1 |
| Aguado Matorras, A | 1 |
| Nalda Felipe, MA | 1 |
| Rzepecki, W | 1 |
| Lukasiewicz, M | 1 |
| Lukasiewicz, E | 1 |
| Harazda, M | 1 |
5 reviews available for succinylcholine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.
Topics: Adult; Anesthetics; Humans; Myasthenia Gravis; Neuromuscular Blocking Agents; Prospective Studies; R | 2022 |
The response of patients with neuromuscular disorders to muscle relaxants: a review.
Topics: Amyotrophic Lateral Sclerosis; Curare; Hemiplegia; Humans; Hyperkalemia; Malignant Hyperthermia; Mul | 1984 |
Characteristics and mechanism of neuromuscular block in myasthenia gravis.
Topics: Acetylcholine; Action Potentials; Animals; Choline; Decamethonium Compounds; Electric Stimulation; E | 1976 |
Neuromuscular blockade.
Topics: Anesthesia, Inhalation; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Cholinesterase Inhibitors; Dr | 1975 |
Mechanisms of neuromuscular block. A review article.
Topics: Acetylcholine; Action Potentials; Animals; Cats; Cell Membrane; Choline; Humans; Membrane Potentials | 1969 |
28 other studies available for succinylcholine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Succinylcholine neuromuscular block in the myasthenia gravis patient.
Topics: Humans; Myasthenia Gravis; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Succinylcholin | 2014 |
Aspects of depolarizing neuromuscular blockers: decamethonium and suxamethonium.
Topics: Bradycardia; Burns; Child; Decamethonium Compounds; Dose-Response Relationship, Drug; Electromyograp | 2013 |
The use of a relaxant in myasthenia gravis.
Topics: Humans; Myasthenia Gravis; Succinylcholine | 1955 |
Safety of succinylcholine in myasthenia gravis.
Topics: Child; Contraindications; Humans; Hyperkalemia; Myasthenia Gravis; Neuromuscular Diseases; Succinylc | 2005 |
Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
Topics: Animals; Autoimmune Diseases; Decamethonium Compounds; Disease Models, Animal; Electrophysiology; Mo | 1983 |
Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis.
Topics: Adult; Apnea; Cholinesterases; Female; Genital Diseases, Female; Humans; Infant, Newborn; Middle Age | 1982 |
Vocal cord paralysis in myasthenia gravis following anesthesia.
Topics: Adult; Anesthesia, General; Female; Humans; Myasthenia Gravis; Respiratory Function Tests; Respirato | 1980 |
Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis receiving long-term anticholinesterase therapy.
Topics: Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Dose-Response Relationship, Drug; Drug Resis | 1994 |
Repeated doses of suxamethonium in the myasthenic patient.
Topics: Adult; Drug Administration Schedule; Electromyography; Female; Humans; Myasthenia Gravis; Neuromuscu | 1993 |
Atypical cholinesterase in a patient with myasthenia gravis.
Topics: Adult; Cesarean Section; Cholinesterases; Evoked Potentials; Female; Homozygote; Humans; Myasthenia | 1977 |
Anaesthesia for mediastinoscopy.
Topics: Anesthesia, General; Humans; Mediastinoscopy; Myasthenia Gravis; Succinylcholine | 1979 |
Damage of skeletal muscle in rats by immunoglobulins. I. Pathophysiological data and lightmicroscopic observations.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Fatigue; Female; Immune Sera; Immunoglobulins; | 1976 |
Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.
Topics: Adolescent; Adult; Aged; Cholinesterases; Female; Humans; Male; Muscle Contraction; Myasthenia Gravi | 1992 |
Onset of neuromuscular block in myasthenic patients.
Topics: Electromyography; Humans; Myasthenia Gravis; Neuromuscular Junction; Succinylcholine; Thymectomy; Ve | 1992 |
Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patients undergoing thymectomy.
Topics: Adult; Electromyography; Female; Humans; Injections, Intravenous; Middle Aged; Myasthenia Gravis; Ne | 1991 |
Response to suxamethonium in a myasthenic patient during remission.
Topics: Anesthesia; Biopsy; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Muscle Contraction; | 1991 |
Resistance to succinylcholine in myasthenia gravis: a dose-response study.
Topics: Adult; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Myasthe | 1988 |
Suxamethonium and myasthenia gravis.
Topics: Humans; Myasthenia Gravis; Neuromuscular Junction; Succinylcholine | 1988 |
Suxamethonium in myasthenia gravis.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Intubation, Intratracheal; Male; Middle Aged; My | 1987 |
Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds.
Topics: Acetylcholine; Adult; Brain; Brain Chemistry; Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Cell | 1971 |
[Apropos of the pathogenesis of myasthenia gravis].
Topics: Adrenocorticotropic Hormone; Animals; Cats; Hydrocortisone; Mice; Myasthenia Gravis; Neuromuscular J | 1966 |
Electromyography in the diagnosis and treatment of myasthenia gravis.
Topics: Acetylcholine; Electromyography; Humans; Myasthenia Gravis; Streptomycin; Succinylcholine; Synaptic | 1968 |
The site and mode of action of propanidid on the peripheral motor unit.
Topics: Action Potentials; Animals; Cell Membrane; Curare; Depression, Chemical; Diaphragm; Drug Synergism; | 1971 |
Neuromuscular effects of halothane, suxamethonium and tubocurarine in a myasthenic undergoing thymectomy.
Topics: Adult; Biopsy; Electromyography; Female; Halothane; Humans; Muscle Contraction; Muscles; Myasthenia | 1971 |
[Previous pathology and anesthesia: paraneoplastic myasthenic-like syndrome].
Topics: Aged; Anesthesia, General; Bronchial Neoplasms; Electromyography; Humans; Lung Neoplasms; Male; Midd | 1973 |
Untoward effects of muscle relaxant drugs.
Topics: Adjuvants, Anesthesia; Amyotrophic Lateral Sclerosis; Anesthesia, Inhalation; Anti-Bacterial Agents; | 1972 |
[Persistent curarization in a case of paraneoplastic myasteniform syndrome].
Topics: Adenocarcinoma; Female; Gallamine Triethiodide; Gastrointestinal Neoplasms; Humans; Middle Aged; Mya | 1970 |
A contribution to the surgical treatment of myasthenia.
Topics: Adult; Anesthesia, General; Female; Halothane; Humans; Male; Methods; Middle Aged; Myasthenia Gravis | 1970 |